1-methyl-1,2,3,4-tetrahydroisoquinoline and Dementia Praecox

1-methyl-1,2,3,4-tetrahydroisoquinoline has been researched along with Dementia Praecox in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Antkiewicz-Michaluk, L; Białoń, M; Chocyk, A; Majcher-Maślanka, I; Michalski, K; Wąsik, A; Żarnowska, M	1

Other Studies

1 other study(ies) available for 1-methyl-1,2,3,4-tetrahydroisoquinoline and Dementia Praecox

Article	Year
1MeTIQ and olanzapine, despite their neurochemical impact, did not ameliorate performance in fear conditioning and social interaction tests in an MK-801 rat model of schizophrenia. Pharmacological reports : PR, 2021, Volume: 73, Issue:2 Topics: Animals; Antipsychotic Agents; Disease Models, Animal; Dizocilpine Maleate; Dopamine; Dopamine Antagonists; Fear; Male; Olanzapine; Rats; Rats, Sprague-Dawley; Schizophrenia; Social Interaction; Tetrahydroisoquinolines	2021

Article

Year

1MeTIQ and olanzapine, despite their neurochemical impact, did not ameliorate performance in fear conditioning and social interaction tests in an MK-801 rat model of schizophrenia.

Pharmacological reports : PR, 2021, Volume: 73, Issue:2

Topics: Animals; Antipsychotic Agents; Disease Models, Animal; Dizocilpine Maleate; Dopamine; Dopamine Antagonists; Fear; Male; Olanzapine; Rats; Rats, Sprague-Dawley; Schizophrenia; Social Interaction; Tetrahydroisoquinolines

2021